Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes

Babalonis, S., Comer, S. D., Jones, J. D., Nuzzo, P., Lofwall, M. R., Manubay, J., Hatton, K. W., Whittington, R. A., & Walsh, S. L. (2021). Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes. Psychopharmacology, 238(9), 2503–2514. https://doi.org/10.1007/s00213-021-05872-1
Authors:
Shanna Babalonis
Sandra D. Comer
Jermaine D. Jones
Paul Nuzzo
Michelle R. Lofwall
Jeanne Manubay
Kevin W. Hatton
Robert A. Whittington
Sharon L. Walsh
Affiliated Authors:
Sandra D. Comer
Jermaine D. Jones
Jeanne Manubay
Robert A. Whittington
Author Keywords:
abuse potential
hydromorphone
intravenous
morphine
opioid
oxycodone
oxymorphone
potency
elink
Publication Type:
Article
Unique ID:
10.1007/s00213-021-05872-1
PMID:
34106317
DOI:
10.1007/s00213-021-05872-1
Journal:
Psychopharmacology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: